XML 49 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 1 Months Ended 12 Months Ended
Dec. 31, 2019
Jan. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:          
Net loss     $ (33,535,748) $ (17,039,898)  
Adjustment to reconcile to net loss to net cash used in operating activities:          
Depreciation expense     45,467 24,328  
Right-of-use asset amortization     113,605 54,977  
Stock based compensation expense     1,802,623 1,086,769  
Net amortization of premium (accretion of discount) on marketable securities     130,240    
Deferred tax benefit     (307,485)    
(Increase) decrease in:          
Accounts receivable     279,713 (290,170)  
Prepaid expenses and other current assets     (2,408,986) (69,740)  
Other assets       (14,333)  
Increase (decrease) in:          
Accounts payable     (130,398) 1,185,589  
Accrued expenses     3,240,940 488,644  
Lease liability     (80,853) (46,991)  
Net cash used in operating activities     (30,850,882) (14,620,825)  
Cash flows from investing activities:          
Purchases of property and equipment     (60,786) (53,415)  
Purchases of marketable securities     (75,625,529)    
Cash acquired in business combination     70,348    
Net cash used in investing activities     (75,615,967) (53,415)  
Cash flows from financing activities:          
Proceeds from initial public offering of common stock, net of commissions and underwriting     120,318,750    
Payment of initial public offering costs     (2,124,317)    
Proceeds from exercise of stock options     354,434    
Proceeds from exercise of warrants     927,125    
Net cash provided by financing activities     144,264,843 37,982,216  
Net increase in cash and cash equivalents     37,797,994 23,307,976  
Cash and cash equivalents at beginning of period   $ 13,782,175 37,090,151 13,782,175  
Cash and cash equivalents at end of period $ 13,782,175   74,888,145 37,090,151 $ 13,782,175
Supplemental disclosures of noncash investing and financing information :          
Conversion of convertible Series A and B preferred stock into common stock     82,892,701    
Business combination non cash     $ 7,804,652    
Class A common stock issued for business combination     7,875,000    
Reclassification of liability for Series A preferred stock       3,509,802  
Series A Preferred Stock          
Cash flows from financing activities:          
Proceeds from the issuance of preferred stock, net of issuance costs $ 4,004,975 1,021,413   998,306  
Payment of initial public offering costs   $ (23,610)     $ (200,587)
Series B Preferred Stock          
Cash flows from financing activities:          
Proceeds from the issuance of preferred stock, net of issuance costs     $ 24,788,851 $ 36,983,910